Leronlimab is too complicated to just "copy" and *
Post# of 148184
(Total Views: 835)
Posted On: 06/20/2020 5:38:28 PM
Re: Goosebumps #38336
Leronlimab is too complicated to just "copy" and *safely* produce it. Expiration of patents means little if you cannot produce the same results with a surrogate.
And it's about waiting for example 5 years, not 12 years. Within 5 years from now we should see a tiny bit of revenue from all those indications.
And it's about waiting for example 5 years, not 12 years. Within 5 years from now we should see a tiny bit of revenue from all those indications.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼